GxP Consulting Announces New Expansion Strategy into US and UK Markets
Nottingham, UK, (Aug 24, 2009) – GxP Consulting, a leading provider of compliance services to the pharmaceutical and biopharmaceutical industries, today announced expansion plans in the US and UK markets. Led by Mark Stevens, managing director at GxP Consulting, the company has launched a strategy to expand services and support to customers in Europe and America in order to help businesses rise to the challenges currently being faced across the industry.
In the current business climate, pharmaceutical and biopharmaceutical industries are facing budget cuts and an increasing need to provide essential regulatory compliance expertise management as cost-effectively as possible. GxP Consulting is helping to overcome these issues and evolving its client tailored solutions, by providing extended services in regulatory compliance, validation project management, computer systems validation and Qualified Person (QP) services.
As part of this expansion, GxP Consulting announces a strategic new facility in Irvine, California, to support increased activity in North America. Secondly, expansion in the UK has led GxP Consulting to move its headquarters into a new larger purpose-built facility in Nottingham. With a dedicated team of 40 consultants in place, GxP Consulting is ideally placed to move forward with its new growth strategy and improved customer support in both regions.
Mark Stevens, Managing Director of GxP Consulting will be spearheading the drive for growth and he brings with him expertise, experience and a world-class team of consultants. Mark is an original founder and director of GxP Consulting. He has been responsible for the successful delivery of projects within the biopharmaceutical, healthcare and food industries in a variety of business areas. During this time he has been involved with engineering design, project management, commissioning, validation, strategic planning and consulting support to corporate leadership teams. This experience covers pre-clinical (GLP), clinical (GCP) manufacturing (GMP) and wholesale / distribution (GDP).
GxP Consulting has extensive experience that captures the full lifecycle of biopharma processes from pre-clinical studies and concept design through to de-commissioning and technology transfer. This includes experience with the setup and approval of biosimilar (biogeneric) and generic operations around the world. The diversity of projects includes hospitals, government facilities, start-up companies and the world’s leading biopharmaceutical and healthcare organizations. This experience has been gathered from a variety of perspectives, including as senior management of operating companies, project directors, principal technical consultants and even as expert witness for legal cases.
The team has a proven track-record of developing biopharmaceutical processes from initial concept through to full-scale manufacturing operations, specializing within the Biotechnology, Pharmaceutical, Consumer Healthcare, Medical Devices, Homeopathic and Veterinary industries. GxP Consulting works with many of the world’s leading healthcare companies providing consulting, contract and training services. It provides highly skilled and experienced teams that are able to deliver a range of knowledge, experience, expertise and help across the entire product lifecycle.
Mark comments: “This is an exciting time for GxP Consulting. We recently marked our ten year anniversary, which is a significant milestone for any business and the next step for us is to push forward with our expansion strategy across both the USA and UK. In the last 12 months, our plans have seen us move to new headquarters in Nottingham, launch a brand new client-centric website and extend our range of services. 2009 is a crucial year for the company as we look to build on our success over the last 12 months, extend our customer support throughout Europe and North America and continue to grow our portfolio of services.”
GxP Consulting provides high-value, pragmatic and experience-based results-focused regulatory compliance services to the pharmaceutical and biopharmaceutical industries. The company has expanded in order to support its growing number of clients with ever increasing requirements of regulatory compliance, covering pre-clinical (GLP), clinical (GCP), manufacturing (GMP) and wholesale storage & distribution – Good Distribution Practice (GDP) business areas.
For more information on GxP Consulting, please call +44 (0) 115 9124547 (EU) or +1 949 725 2946 (US), email info@gxpeu.com (EU) or info@gxpus.com (US). Alternatively please visit http://www.gxpeu.com (EU) or http://www.gxpus.com (US) for further information.
